CN116672421A - A topical composition for preventing and treating myopia, and its preparation method - Google Patents
A topical composition for preventing and treating myopia, and its preparation method Download PDFInfo
- Publication number
- CN116672421A CN116672421A CN202310435664.XA CN202310435664A CN116672421A CN 116672421 A CN116672421 A CN 116672421A CN 202310435664 A CN202310435664 A CN 202310435664A CN 116672421 A CN116672421 A CN 116672421A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- preparation
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004379 myopia Effects 0.000 title claims abstract description 33
- 208000001491 myopia Diseases 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 230000000699 topical effect Effects 0.000 title claims description 12
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 28
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 28
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 24
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 24
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000008434 ginseng Nutrition 0.000 claims abstract description 24
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims abstract description 24
- 239000006071 cream Substances 0.000 claims abstract description 22
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 17
- 241000893536 Epimedium Species 0.000 claims abstract description 17
- 241001071795 Gentiana Species 0.000 claims abstract description 17
- 241000132446 Inula Species 0.000 claims abstract description 17
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 17
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 17
- 235000018905 epimedium Nutrition 0.000 claims abstract description 17
- 244000112814 pipewort Species 0.000 claims abstract description 16
- 230000004438 eyesight Effects 0.000 claims abstract description 12
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 11
- 241000329195 Sparganium erectum Species 0.000 claims abstract description 7
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 6
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 6
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 6
- 241000475481 Nebula Species 0.000 claims abstract description 6
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 6
- 240000003538 Chamaemelum nobile Species 0.000 claims abstract description 5
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 5
- 241000545744 Hirudinea Species 0.000 claims abstract description 5
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 5
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 5
- 235000005272 common selfheal Nutrition 0.000 claims abstract description 5
- 239000004863 Frankincense Substances 0.000 claims abstract description 4
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 4
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 52
- 239000000843 powder Substances 0.000 claims description 44
- 239000003814 drug Substances 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- 241000628997 Flos Species 0.000 claims description 22
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 18
- 238000009835 boiling Methods 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 241000207925 Leonurus Species 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 15
- 239000010446 mirabilite Substances 0.000 claims description 15
- 239000008280 blood Substances 0.000 claims description 14
- 210000004369 blood Anatomy 0.000 claims description 14
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 12
- 239000000839 emulsion Substances 0.000 claims description 12
- 235000008113 selfheal Nutrition 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 12
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 11
- 235000006533 astragalus Nutrition 0.000 claims description 11
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 11
- 229940116229 borneol Drugs 0.000 claims description 11
- 241000045403 Astragalus propinquus Species 0.000 claims description 10
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 10
- 235000008599 Poria cocos Nutrition 0.000 claims description 10
- 244000197580 Poria cocos Species 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 244000061520 Angelica archangelica Species 0.000 claims description 8
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 8
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 8
- 229920003081 Povidone K 30 Polymers 0.000 claims description 8
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 8
- 229960004063 propylene glycol Drugs 0.000 claims description 8
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 7
- 229940041616 menthol Drugs 0.000 claims description 7
- 239000002674 ointment Substances 0.000 claims description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 6
- 229910021538 borax Inorganic materials 0.000 claims description 6
- 239000000469 ethanolic extract Substances 0.000 claims description 6
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 6
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 6
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 6
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- 229960005150 glycerol Drugs 0.000 claims description 6
- 229960005323 phenoxyethanol Drugs 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000004328 sodium tetraborate Substances 0.000 claims description 6
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 claims description 5
- 241000159213 Zygophyllaceae Species 0.000 claims description 5
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 5
- 239000003889 eye drop Substances 0.000 claims description 5
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 5
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 5
- 235000009165 saligot Nutrition 0.000 claims description 5
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 5
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 4
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000003906 humectant Substances 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- DTGKSKDOIYIVQL-NQMVMOMDSA-N (+)-Borneol Natural products C1C[C@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-NQMVMOMDSA-N 0.000 claims description 3
- 229920000742 Cotton Polymers 0.000 claims description 3
- 240000002624 Mespilus germanica Species 0.000 claims description 3
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 3
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 3
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 3
- 230000007812 deficiency Effects 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 3
- 208000030533 eye disease Diseases 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000005728 strengthening Methods 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- 229920002498 Beta-glucan Polymers 0.000 claims description 2
- 241000723346 Cinnamomum camphora Species 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 235000017276 Salvia Nutrition 0.000 claims description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 229930008380 camphor Natural products 0.000 claims description 2
- 229960000846 camphor Drugs 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- 150000001783 ceramides Chemical class 0.000 claims description 2
- 230000004087 circulation Effects 0.000 claims description 2
- 239000010642 eucalyptus oil Substances 0.000 claims description 2
- 229940044949 eucalyptus oil Drugs 0.000 claims description 2
- 229940051250 hexylene glycol Drugs 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 229960002969 oleic acid Drugs 0.000 claims description 2
- 229940101267 panthenol Drugs 0.000 claims description 2
- 235000020957 pantothenol Nutrition 0.000 claims description 2
- 239000011619 pantothenol Substances 0.000 claims description 2
- 230000001717 pathogenic effect Effects 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 238000010926 purge Methods 0.000 claims description 2
- 229940071139 pyrrolidone carboxylate Drugs 0.000 claims description 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 claims description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 230000001502 supplementing effect Effects 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- 241000382455 Angelica sinensis Species 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 210000005036 nerve Anatomy 0.000 claims 2
- 210000000582 semen Anatomy 0.000 claims 2
- 241001061264 Astragalus Species 0.000 claims 1
- 241000717739 Boswellia sacra Species 0.000 claims 1
- 241000756943 Codonopsis Species 0.000 claims 1
- 244000293323 Cosmos caudatus Species 0.000 claims 1
- 235000005956 Cosmos caudatus Nutrition 0.000 claims 1
- 241000237903 Hirudo Species 0.000 claims 1
- 241000217407 Margaritifera Species 0.000 claims 1
- 241001057584 Myrrha Species 0.000 claims 1
- 241000180649 Panax notoginseng Species 0.000 claims 1
- 235000003143 Panax notoginseng Nutrition 0.000 claims 1
- 210000004233 talus Anatomy 0.000 claims 1
- 241000213006 Angelica dahurica Species 0.000 abstract description 9
- 229940107666 astragalus root Drugs 0.000 abstract description 4
- 244000144730 Amygdalus persica Species 0.000 abstract description 3
- 241000132012 Atractylodes Species 0.000 abstract description 3
- 235000003717 Boswellia sacra Nutrition 0.000 abstract description 3
- 235000012035 Boswellia serrata Nutrition 0.000 abstract description 3
- 240000007551 Boswellia serrata Species 0.000 abstract description 3
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 3
- 240000007311 Commiphora myrrha Species 0.000 abstract description 3
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract description 3
- 240000005717 Dioscorea alata Species 0.000 abstract description 3
- 244000246386 Mentha pulegium Species 0.000 abstract description 3
- 235000016257 Mentha pulegium Nutrition 0.000 abstract description 3
- 235000004357 Mentha x piperita Nutrition 0.000 abstract description 3
- 235000008708 Morus alba Nutrition 0.000 abstract description 3
- 240000000249 Morus alba Species 0.000 abstract description 3
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 3
- 240000002948 Ophiopogon intermedius Species 0.000 abstract description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract description 3
- 241000405414 Rehmannia Species 0.000 abstract description 3
- 241000951473 Schizonepeta Species 0.000 abstract description 3
- 241000913745 Spatholobus Species 0.000 abstract description 3
- 235000001050 hortel pimenta Nutrition 0.000 abstract description 3
- 235000017524 noni Nutrition 0.000 abstract description 3
- 244000183685 Citrus aurantium Species 0.000 abstract description 2
- 235000007716 Citrus aurantium Nutrition 0.000 abstract description 2
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract description 2
- 240000009138 Curcuma zedoaria Species 0.000 abstract description 2
- 241001547127 Fritillaria cirrhosa Species 0.000 abstract description 2
- 241000212322 Levisticum officinale Species 0.000 abstract description 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract description 2
- 235000008898 Morinda citrifolia Nutrition 0.000 abstract description 2
- 244000131360 Morinda citrifolia Species 0.000 abstract description 2
- 235000008248 Morinda citrifolia var citrifolia Nutrition 0.000 abstract description 2
- 241001521901 Tribulus lanuginosus Species 0.000 abstract description 2
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract description 2
- 239000001645 levisticum officinale Substances 0.000 abstract description 2
- 235000005412 red sage Nutrition 0.000 abstract description 2
- 235000019509 white turmeric Nutrition 0.000 abstract description 2
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 63
- 238000012360 testing method Methods 0.000 description 23
- 210000005252 bulbus oculi Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 210000004087 cornea Anatomy 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 206010015946 Eye irritation Diseases 0.000 description 7
- 231100000013 eye irritation Toxicity 0.000 description 7
- 210000000795 conjunctiva Anatomy 0.000 description 6
- 210000000554 iris Anatomy 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 5
- 235000021028 berry Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 229940124532 absorption promoter Drugs 0.000 description 4
- 208000003464 asthenopia Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 239000011505 plaster Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000001747 pupil Anatomy 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000006196 drop Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 235000013073 Acorus gramineus Nutrition 0.000 description 2
- 244000001632 Acorus gramineus Species 0.000 description 2
- 206010030043 Ocular hypertension Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000283977 Oryctolagus Species 0.000 description 2
- 241001111421 Pannus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000004308 accommodation Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 210000003161 choroid Anatomy 0.000 description 2
- 230000001886 ciliary effect Effects 0.000 description 2
- 210000000695 crystalline len Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 2
- -1 external eye patches Substances 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000004410 intraocular pressure Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229940023490 ophthalmic product Drugs 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 241001633583 Adenophora Species 0.000 description 1
- 241001412627 Adenophora liliifolia Species 0.000 description 1
- 206010001526 Air embolism Diseases 0.000 description 1
- 235000011202 Angiopteris lygodiifolia Nutrition 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000007126 Codonopsis pilosula Species 0.000 description 1
- 241000510667 Conioselinum Species 0.000 description 1
- 244000241463 Cullen corylifolium Species 0.000 description 1
- 241000723185 Cyathea Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 241000605372 Fritillaria Species 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 241000157491 Morinda Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 239000009759 San-Chi Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000007488 abnormal function Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SZGZILRQIYNODJ-UHFFFAOYSA-L disodium;7,12-dihydroquinoxalino[3,2-b]phenazine-2,9-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=C2N=C(C=C3C(NC4=CC=C(C=C4N3)S(=O)(=O)[O-])=C3)C3=NC2=C1 SZGZILRQIYNODJ-UHFFFAOYSA-L 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 231100000286 mucous membrane, eye irritation or corrosion testing Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004515 progressive myopia Effects 0.000 description 1
- 230000004436 pseudomyopia Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an external composition for preventing and treating myopia and a preparation method thereof, which is characterized in that the external composition is prepared from common selfheal fruit-spike, kelp, radix trichosanthis, airpotato yam, fritillaria cirrhosa, inula flower, mirabilitum, bitter orange, common burreed rhizome, zedoary, peach kernel, leech, puerarin, ginkgo leaf, chinese angelica, safflower, szechuan lovage rhizome, pseudo-ginseng, motherwort fruit, suberect spatholobus stem, frankincense, myrrh and red sage root, and pipewort herb, chamomile, fructus broussonetiae, tribulus terrestris, cassia seed, pearl, mother-of-pearl, concha haliotidis, mulberry leaf, gentian, peppermint and fineleaf schizonepeta herb, as well as ginseng, pilose asiabell root, astragalus root, largehead atractylodes rhizome, dried rehmannia root, radix asparagi, dwarf lilyturf root, glossy privet fruit, root, epimedium herb, medicinal indian mulberry root, rhizoma polygonati, chinese magnoliavine fruit, fructus psoraleae, white paeony root, chinese wolfberry fruit and the like which have the functions of dispelling wind and clearing heat, improving eyesight and removing nebula, and the external eye paste, cream, preparation, and the product of the external composition for preventing and treating myopia are prepared.
Description
Technical Field
The invention belongs to the technical field of ophthalmic medicines of pharmaceutical preparations, and in particular relates to an external composition for preventing and treating myopia and a preparation method thereof.
Background
The incidence rate of myopia in China is very high, the incidence rate of myopia of pupil reaches 35.6%, the incidence rate of myopia of junior middle school students reaches 71.1%, the incidence rate of myopia of senior middle school students reaches 80.3%, and the incidence rate of myopia of college students reaches 87%, so that the pupil is in the trend of high-incidence, low-age and rapid progress. It seriously affects study, work and life of people, and has high risk of diseases such as retinal detachment, cataract, glaucoma, macular degeneration and the like for highly myopic people. Previously, people recognize myopia, which is mostly thought to be caused by poor accommodation of eyes with long-term close distance, i.e., by excessive ciliary muscle accommodation. Therefore, most of the treatments from drug research are drug development and treatment based on the theory, and the effect is of course not ideal. Song Xinjiang et al in the book "cause and prevention and progression of myopia" indicate that "the immediate cause of myopia formation is higher ocular pressure, which results from a regulated pupil block and ciliary muscle longitudinal fiber relaxation, scleral spur drop, small Liang Wangyan, and increased resistance to aqueous humor excretion. It is caused by the fact that ocular hypertension expansion pressure acts on the eyeball wall to gradually enlarge the eyeball and prolong the ocular axis, and is never caused by the fact that pseudomyopia continues to develop and finally true myopia is formed. "New forum". According to the new theory, the inventor combines the traditional Chinese medicine theory of China, and the invention is obtained through technical innovation in the research of long-term focus on ophthalmic medicines and eye health care products.
Disclosure of Invention
The invention aims to provide an external composition for preventing and treating myopia, fundus disease and eye fatigue, and the medicine composition of the invention has the following principle: because the long-term ocular hypertension causes the expansion of the eyeballs as the main cause, the intraocular pressure must be reduced, the expansion of the eyeballs can be reduced, the expansion of the eyeballs and the extension of the ocular axes can be reduced, according to the traditional Chinese medicine theory of China, the functions of resolving hard mass, detumescence, purging pathogenic fire, reducing qi, reducing the like traditional Chinese medicines including selfheal, kelp, radix trichosanthis, airpotato yam, fritillaria, inula flower, mirabilite, fructus aurantii, blood breaking, stasis dispelling, qi-promoting and pain relieving like traditional Chinese medicines including rhizoma sparganii, rhizoma curcumae, peach kernel, leech, puerarin, ginkgo leaf, angelica, safflower, hemlock parsley, pseudo-ginseng, motherwort fruit, suberect spatholobus stem, frankincense, myrrh and radix salviae miltiorrhizae are achieved, the effects of reducing intraocular pressure, preventing abnormal expansion of the eyeballs, reducing the expansion of the eyeballs and the extension of the ocular axes are achieved, accelerating the blood circulation of the eyes and accelerating the metabolism of the eyes are achieved, the Chinese medicinal materials such as pipewort, chamomile, fructus broussonetiae, caltrop, cassia seed, pearl, mother of pearl (layer powder), concha haliotidis, mulberry leaf, gentian, peppermint and herba schizonepetae are matched to serve as ministerial medicaments, cooperate with monarch medicaments to play roles in improving eyesight and removing nebula, dispelling wind and clearing heat, supplementing eye nutrition, and are matched with deficiency-tonifying Chinese medicaments such as ginseng, codonopsis pilosula, astragalus root, bighead atractylodes rhizome, radix rehmanniae, radix asparagi, dwarf lilyturf tuber, glossy privet fruit, adenophora root, epimedium herb, morinda root, rhizoma cibotii, fructus psoraleae, medlar, rhizoma polygonati, shizandra berry, white poria, grassleaf sweetflag rhizome and the like to supplement vital energy and blood of human body caused by overuse of eyes and consumption of essence and blood of eyes; liver and kidney are homologous, and liver and kidney are unbalanced, so that kidney essence deficiency is caused; the traditional Chinese medicine prevents myopia, protects vision, and achieves balance of yin and yang, and balance of qi and blood, by virtue of the fact that essence and blood are generated mutually and yin and yang are mutually balanced, and simultaneously the effect of simultaneously decreasing the blood and the yang is achieved from the same time of tonifying liver and kidney; the liver and kidney are full of essence and blood, so that eyes are nourished, namely various physiological functions of eyes are improved, the capability of the eyes to resist the influence of external adverse factors is improved, abnormal functions are corrected, and a visual system plays a normal role; in addition, the transdermal absorption promoter used in the preparation, such as borneol, natural borneol (d-borneol), menthol, azone and the like, promotes the absorption of the medicine, and enables the medicine to directly reach the action part, thus being a good medicine for preventing and treating myopia, preventing and slowing down fundus lesions and preventing eyestrain.
In summary, the invention is characterized in that the Chinese medicines of common selfheal fruit-spike, kelp, radix trichosanthis, airpotato yam rhizome, fritillaria cirrhosa, inula flower, mirabilite, bitter orange, common burreed rhizome, zedoary, peach seed, leech, puerarin, ginkgo leaf, chinese angelica, safflower, szechuan lovage rhizome, sanchi, motherwort fruit, suberect spatholobus stem, frankincense, myrrh and red sage root are used for resolving hard mass and detumescence, eyesight improving and nebula removing, chinese medicines of pipewort, chamomile, fructus broussonetiae, tribulus terrestris, cassia seed, pearl, nacre (layer powder), concha haliotidis, mulberry leaf, gentian, peppermint and fineleaf schizonepeta herb are matched, and then is matched with deficiency-tonifying traditional Chinese medicines such as ginseng, pilose asiabell root, astragalus root, largehead atractylodes rhizome, dried rehmannia root, cochinchnese asparagus root, dwarf lilyturf tuber, glossy privet fruit, straight ladybell root, epimedium herb, medicinal indianmulberry root, east Asian tree fern rhizome, malaytea scurfpea fruit, barbary wolfberry fruit, manyflower solomonseal rhizome, chinese magnoliavine fruit, white poria, grassleaf sweetflag rhizome and the like, and finally is added with transdermal absorption promoters such as borneol and/or natural borneol (right-handed borneol), menthol, azone and the like, and the transdermal absorption promoters are prepared into products such as external eye patches, ointments, creams, emulsions, emplastrum and the like for preventing and treating myopia, preventing and relieving eyestrain and preventing eyestrain.
The traditional Chinese medicine composition is prepared from common selfheal fruit-spike, kelp, radix trichosanthis, inula flower, mirabilite, fructus aurantii, traditional Chinese medicines of removing blood stasis, promoting circulation of qi and relieving pain, rhizoma sparganii, rhizoma curcumae, leech, puerarin, ginkgo leaf, chinese angelica, safflower, pseudo-ginseng, motherwort fruit and root of red-rooted salvia, traditional Chinese medicines of dispelling wind and clearing heat, improving eyesight and removing nebula, such as pipewort, chamomile, fructus Broussonetiae, caltrop, nacre (layer powder), concha haliotidis, gentian and schizonepeta, and traditional Chinese medicines of tonifying qi and nourishing blood, tranquillizing and improving intelligence, nourishing yin and strengthening yang, such as ginseng, astragalus mongholicus, radix rehmanniae, radix asparagi, glossy privet fruit, epimedium, fructus psoraleae, medlar, schisandra chinensis, poria cocos, rhizoma acori graminei and the like.
The traditional Chinese medicine is prepared from common selfheal fruit-spike, kelp, inula flower, mirabilite, common burreed rhizome, puerarin, chinese angelica, safflower, motherwort fruit, chinese angelica root, common burreed rhizome, kudzuvine root, chinese angelica, common burreed rhizome, fructus Broussonetiae, caltrop, mother-of-pearl (layer powder) and gentian, and further comprises the traditional Chinese medicines of replenishing qi and nourishing blood, tranquillizing and developing intelligence, nourishing yin and strengthening yang, ginseng, astragalus root, dried rehmannia root, radix asparagi, epimedium, chinese magnoliavine fruit, white poria, grassleaf sweelflag rhizome and the like.
The optimal carefully chosen formula comprises the following components in parts by weight: 3-12 parts of selfheal, 3-12 parts of kelp, 4-18 parts of inula flower, 1-9 parts of mirabilite, 2-10 parts of rhizoma sparganii, 0.2-2 parts of puerarin, 5-15 parts of angelica, 2-10 parts of safflower, 3-12 parts of motherwort fruit, 3-18 parts of pipewort, 2-10 parts of fructus Broussonetiae, 1-8 parts of fructus tribuli, 10-50 parts of pearl powder, 0.5-5 parts of gentian, 2-10 parts of ginseng, 3-12 parts of astragalus mongholicus, 3-15 parts of radix rehmanniae, 3-15 parts of radix asparagi, 5-20 parts of epimedium, 1-6 parts of schisandra chinensis, 3-12 parts of poria cocos and 1-6 parts of rhizoma acori graminei. The above Chinese medicinal materials are used for extracting effective components according to their characteristics and medicinal requirements, and adding pharmaceutically acceptable adjuvants into the extracts to make into topical preparations for eye such as patch, unguent, cream, emulsion, patch, etc.
The optimal carefully chosen formula is optimized according to parts by weight: 5-10 parts of selfheal, 5-10 parts of kelp, 6-15 parts of inula flower, 2-8 parts of mirabilite, 3-9 parts of rhizoma sparganii, 0.3-1.5 parts of puerarin, 6-12 parts of angelica, 3-8 parts of safflower, 5-10 parts of motherwort fruit, 20-40 parts of pearl powder, 6-15 parts of pipewort, 3-8 parts of fructus Broussonetiae, 2-7 parts of fructus tribuli, 0.8-4 parts of gentian, 2-8 parts of ginseng, 4-10 parts of radix astragali, 5-12 parts of radix rehmanniae, 5-12 parts of radix asparagi, 6-16 parts of epimedium, 2-6 parts of schisandra chinensis, 5-10 parts of white poria and 2-6 parts of rhizoma acori graminei. The above Chinese medicinal materials are used for extracting effective components according to their characteristics and administration requirements, and adding various extracts into pharmaceutically acceptable adjuvants to make into topical preparations for eye such as patch, unguent, cream, emulsion, patch, etc.
The optimal further carefully selected formula is further optimized according to parts by weight: 6-9 parts of selfheal, 6-9 parts of kelp, 8-14 parts of inula flower, 3-8 parts of mirabilite, 4-9 parts of rhizoma sparganii, 0.5-1.2 parts of puerarin, 8-10 parts of angelica, 4-6 parts of safflower, 6-9 parts of motherwort fruit, 22-36 parts of pearl powder, 8-12 parts of pipewort, 4-6 parts of fructus Broussonetiae, 2-6 parts of fructus tribuli, 1-3 parts of gentian, 2-6 parts of ginseng, 4-8 parts of astragalus mongholicus, 6-12 parts of radix rehmanniae, 8-12 parts of radix asparagi, 8-15 parts of epimedium, 2-5 parts of schisandra chinensis, 5-9 parts of poria cocos and 2-5 parts of rhizoma acori graminei. The above Chinese medicinal materials are extracted according to their respective characteristics and requirements, and various extracts are added into pharmaceutically acceptable adjuvants to make into topical preparations for eye such as patch, unguent, cream, emulsion, patch, etc.
The composition is characterized by further comprising a percutaneous absorption promoter, a humectant and auxiliary materials acceptable by pharmaceutical preparations.
The transdermal absorption enhancer comprises one or more of borneol, natural borneol (d-borneol), menthol, camphor, eucalyptus oil, oleic acid, azone, dimethyl sulfoxide and the like.
The humectant includes, but is not limited to, one or more of trehalose, oat beta-glucan, polyethylene glycol, glycerol, propylene glycol, butylene glycol, hexylene glycol, xylitol, sorbitol, PVP-K30, sodium hyaluronate, panthenol, ceramides, sodium Pyrrolidone Carboxylate (PCA).
The external composition for preventing and treating myopia and the preparation method thereof are characterized by comprising the following steps:
(1) Pulverizing Inulae flos, rhizoma Sparganii, radix Angelicae sinensis, fructus Leonuri, flos Eriocauli, fructus Tribuli, and rhizoma Acori Graminei into coarse powder, distilling with steam, extracting volatile oil, and storing in a container;
(2) Adding Prunellae Spica, thallus laminariae, carthami flos, fructus Broussonetiae, ginseng radix, radix astragali, radix rehmanniae, radix asparagi, and Poria into the medicinal liquid and residue after extracting volatile oil; decocting herba Epimedii, fructus Schisandrae chinensis, and radix Gentianae with water twice, adding 10 times of water for the first time, boiling for 3 hr, adding 8 times of water for the second time, boiling for 2 hr, filtering, concentrating the extractive solution, adding ethanol to precipitate for two times until ethanol content is 50-80%, and recovering ethanol to obtain Chinese medicinal extract;
(3) Adding 3-8% water into nacreous layer powder, boiling, maintaining the temperature for 6-60 hr, filtering, and concentrating to obtain nacreous layer powder extractive solution.
(4) Adding nacreous layer powder extract into the Chinese medicinal extract, stirring, adding borax, mirabilitum, PVP-K30 and puerarin, stirring for dissolving;
(5) And (3) adding the solubilizing agent Tween-80 into the extracted volatile oil, uniformly mixing, adding the volatile oil into the liquid medicine prepared in the step (4), uniformly mixing, and adding glycerol, propylene glycol, phenoxyethanol and ethylparaben, and stirring to dissolve. And finally, slowly adding the natural borneol and menthol ethanol solution under stirring, regulating the pH value to be between 6.4 and 7.8 by using disodium hydrogen phosphate solution or sodium dihydrogen phosphate solution, adding water to the whole amount, uniformly mixing, filtering, filling into an eye-protecting adhesive carrier such as pure cotton cloth, natural silk cloth aluminum-plastic composite film bag or other containers which are cut into a certain shape, and sealing.
The external composition for preventing and treating myopia and the preparation method thereof are characterized by comprising the following steps:
A. pulverizing Inulae flos, rhizoma Sparganii, radix Angelicae sinensis, fructus Leonuri, flos Eriocauli, fructus Tribuli, herba Epimedii, fructus Schisandrae chinensis, radix Gentianae, and rhizoma Acori Graminei into coarse powder, adding 60-85% ethanol solution of 6-8 times of the powder, ultrasonic extracting the ethanol soaked material for 1.5 hr, filtering, adding 3-4 times 60-85% ethanol solution into the residue, ultrasonic extracting for 1.0 hr, and filtering. Combining the two filtrates, and recovering ethanol. Obtaining ethanol extract.
B. Decocting Prunellae Spica, thallus laminariae, carthami flos, fructus Broussonetiae, ginseng radix, radix astragali, radix rehmanniae, radix asparagi, and Poria with water twice, adding 10 times of water in the first time, boiling for 3 hr, adding 8 times of water in the second time, boiling for 2 hr, filtering, mixing filtrates, and concentrating to obtain Chinese medicinal extract;
C. adding 3-8% water into nacreous layer powder, boiling, maintaining the temperature for 6-60 hr, filtering, and concentrating to obtain nacreous layer powder extractive solution.
D. Adding nacreous layer powder extract and ethanol extract into the Chinese medicinal extract, stirring, mixing, adding borax, mirabilitum, and Tween-80 as solubilizer, PVP-K30 and puerarin, natural Borneolum Syntheticum, mentholum, glycerol, propylene glycol, phenoxyethanol, and ethylparaben, stirring, mixing, adding adjuvant, and adjusting pH to 6.4-7.8 with disodium hydrogen phosphate solution or sodium dihydrogen phosphate solution to obtain eye massage cream; or adding emulsion matrix, etc., and making into cream, lotion, patch, etc.
Description of the embodiments
In accordance with the present disclosure, the following detailed procedure is presented.
1. Example 1
One of the eye protection patches is made, and the eye protection patch comprises the following components in parts by weight: 6 parts of selfheal, 6 parts of kelp, 10 parts of inula flower, 3 parts of mirabilite, 6 parts of rhizoma sparganii, 1 part of puerarin, 8 parts of Chinese angelica, 4 parts of safflower, 6 parts of motherwort fruit, 30 parts of pearl powder, 9 parts of pipewort, 4 parts of fructus Broussonetiae, 3 parts of fructus tribuli, 1 part of gentian, 3 parts of ginseng, 4 parts of astragalus mongholicus, 7 parts of radix rehmanniae, 9 parts of radix asparagi, 10 parts of epimedium, 3 parts of shizandra berry, 6 parts of white poria cocos, and 3 parts of rhizoma acori graminei.
The preparation method comprises the following steps:
(1) Pulverizing Inulae flos, rhizoma Sparganii, radix Angelicae sinensis, fructus Leonuri, fructus Tribuli, flos Eriocauli, and rhizoma Acori Graminei into coarse powder, distilling with steam, extracting volatile oil, and storing in a container;
(2) Adding Prunellae Spica, thallus laminariae, carthami flos, fructus Broussonetiae, ginseng radix, radix astragali, radix rehmanniae, radix asparagi, poria, herba Epimedii, fructus Schisandrae chinensis, and radix Gentianae into the medicinal liquid and residue after extracting volatile oil, decocting with water twice, adding 10 times of water for the first time, boiling for 3 hr, adding 8 times of water for the second time, boiling for 2 hr, concentrating the extractive solution, adding ethanol until ethanol content is 50-75%, precipitating twice, and recovering ethanol to obtain the final medicinal extract;
(3) Adding 3-8% water into nacreous layer powder, boiling, maintaining for 12-60 hr, filtering, and concentrating to obtain nacreous layer powder extractive solution.
(4) Adding nacreous layer powder extract into the Chinese medicinal extract, stirring, mixing, adding Mirabilitum, borax, PVP-K30 and puerarin, stirring to dissolve;
(5) And (3) adding the extracted volatile oil into the solubilizing agent Tween-80, uniformly mixing, adding the volatile oil into the liquid medicine prepared in the step (4), uniformly mixing, and adding glycerol, propylene glycol, phenoxyethanol and ethylparaben, and stirring for dissolving. And finally, slowly adding the natural borneol and menthol ethanol solution under stirring, regulating the pH value to be between 6.4 and 7.8 by using disodium hydrogen phosphate solution or sodium dihydrogen phosphate solution, adding water to the whole amount, uniformly mixing, filtering, filling into an eye-protecting adhesive carrier such as pure cotton cloth, natural silk cloth aluminum-plastic composite film bag or other containers which are cut into a certain shape, and sealing.
2. Example two
The second eye-protecting patch is prepared from the following components in parts by weight: 9 parts of selfheal, 9 parts of kelp, 12 parts of inula flower, 6 parts of mirabilite, 9 parts of rhizoma sparganii, 0.75 part of puerarin, 10 parts of angelica, 5 parts of safflower, 9 parts of motherwort fruit, 33 parts of pearl powder, 12 parts of pipewort, 5 parts of fructus Broussonetiae, 4 parts of fructus tribuli, 2 parts of gentian, 4 parts of ginseng, 6 parts of astragalus membranaceus, 10 parts of radix rehmanniae, 12 parts of radix asparagi, 12 parts of epimedium, 3 parts of shizandra berry, 6 parts of white poria cocos, and 3 parts of rhizoma acori graminei.
The preparation method is the same as in example one.
3. Example III
The eye massage cream is prepared from the following components in parts by weight: 9 parts of selfheal, 9 parts of kelp, 9 parts of inula flower, 6 parts of mirabilite, 8 parts of rhizoma sparganii, 1 part of puerarin, 9 parts of Chinese angelica, 5 parts of safflower, 9 parts of motherwort fruit, 32 parts of pearl powder, 12 parts of pipewort, 6 parts of fructus Broussonetiae, 6 parts of fructus tribuli, 2 parts of gentian, 4 parts of ginseng, 6 parts of astragalus membranaceus, 10 parts of radix rehmanniae, 12 parts of radix asparagi, 12 parts of epimedium, 3 parts of shizandra berry, 6 parts of white poria cocos, and 3 parts of rhizoma acori graminei.
The preparation method comprises the following steps:
A. pulverizing Inulae flos, rhizoma Sparganii, radix Angelicae sinensis, fructus Leonuri, flos Eriocauli, fructus Tribuli, herba Epimedii, fructus Schisandrae chinensis, radix Gentianae, and rhizoma Acori Graminei into coarse powder, adding 60-85% ethanol solution with the amount of 6-8 times of the powder, ultrasonic extracting the ethanol soaked material for 2 hr, filtering, and recovering ethanol from the filtrate. Obtaining ethanol extract.
B. Adding 6-10 times of water into Prunellae Spica, thallus laminariae, carthami flos, fructus Broussonetiae, ginseng radix, radix astragali, radix rehmanniae, radix asparagi and Poria, decocting with water twice, adding 10 times of water in the first time, boiling for 2 hr, adding 8 times of water in the second time, boiling for 1.5 hr, concentrating the extractive solution, adding ethanol until ethanol content is 50-75%, precipitating twice, and recovering ethanol to obtain Chinese medicinal extract;
C. adding 3-8% water into nacreous layer powder, boiling, maintaining for 12-60 hr, filtering, and concentrating to obtain nacreous layer powder extractive solution.
D. Adding nacreous layer powder extract into the Chinese medicinal extract, stirring, adding borax, mirabilitum, and solubilizing agent Tween-80 and ethanol extract, PVP-K30 and puerarin, natural Borneolum Syntheticum, mentholum, glycerol, propylene glycol, phenoxyethanol, and ethylparaben, stirring, adding adjuvant, and making into eye massage cream;
3. example IV
The eye emulsion is prepared from the following components in parts by weight: 8 parts of selfheal, 8 parts of kelp, 10 parts of inula flower, 6 parts of mirabilite, 9 parts of rhizoma sparganii, 1 part of puerarin, 10 parts of Chinese angelica, 5 parts of safflower, 9 parts of motherwort fruit, 28 parts of pearl powder, 12 parts of pipewort, 6 parts of fructus Broussonetiae, 6 parts of fructus tribuli, 2 parts of gentian, 4 parts of ginseng, 6 parts of astragalus membranaceus, 12 parts of radix rehmanniae, 12 parts of radix asparagi, 12 parts of epimedium, 3 parts of shizandra berry, 6 parts of white poria cocos, and 3 parts of rhizoma acori graminei.
The preparation method is basically the same as that of the third embodiment, and the eye massage emulsion is prepared by adding the emulsion auxiliary materials after all materials are added.
5. Example five
Local skin irritation test
12 adult New Zealand rabbits are taken, the common level is not limited, the weight of the rabbits is 2.0 to 3. okg, the rabbits are divided into two groups, one group is an eye patch group, and the other group is eye massage cream. The hairs on both sides of the back spine of the experimental animal are cut off (the epidermis can not be damaged) 24 hours before the experiment, and the hair removing range is about 5cm multiplied by 8cm on the left and right sides. By adopting a self-contrast method, the left side of each rabbit in the first group is applied with 4.5 cm multiplied by 7.5 cm eye protection patches (experiments) prepared in the second embodiment of the invention, the right side is applied with 4.5 cm multiplied by 7.5 cm physiological saline patches (contrast), and the two patches are continuously applied for 7d three times a day for 30 minutes each time. The eye massage cream prepared in the third embodiment of the present invention was applied to the left side of each rabbit in the second group (test), and physiological saline was applied to the right side (control), three times a day, followed by administration for 7d. Skin changes were observed immediately after each dose and about 2 hours after the dose and 1, 6, 12, 24, h after the last dose on day 7. Scoring was performed according to the skin irritation assay scoring criteria of table 1.
TABLE 1 skin irritation test scoring criteria
Test results: see table 2.
TABLE 2 skin irritation response score table
Conclusion: the test result shows that the eye protection plaster and the eye massage cream prepared by the composition have no skin irritation.
6. Example six eye stimulatory experiments were performed on 12 adult New Zealand rabbits, normal grade, with no limitation on male and female, and a body weight of 2.0-3. okg. Prior to the test, visual inspection: the cornea is free from turbidity, conjunctiva congestion, edema and secretion, pupil is round, two sides are equal, and the light reflection is good. Slit lamp inspection: the cornea is transparent and has no pannus and pannus; clear iris texture and no congestion and edema. 1% sodium fluorescein is used as an eye drop, each rabbit is washed clean by normal saline after dropping one drop, and then observed by a slit lamp, and the cornea is normal when the cornea is not stained. The eye mask is divided into two groups, wherein the first group is an eye mask liquid medicine group prepared according to the second embodiment of the invention, and the second group is an eye massage cream group prepared according to the third embodiment of the invention, and a left eye self-comparison method and a right eye self-comparison method are respectively adopted. The eye protection patch medicine liquid (test) prepared in the second embodiment of the invention is dropped into the left eye of each rabbit in the first group, physiological saline is dropped into the right eye (control), and then the eyelid is gently closed for about 10 seconds each time, and the medicine liquid is continuously administrated for 7d three times a day. In the second group, the right eye of each rabbit was coated with an appropriate amount of the eye massage cream prepared in the third embodiment of the present invention (test), and the right eye was dropped with physiological saline (control), one drop at a time, and then the eyelid was gently closed for about 10 seconds, three times a day, followed by administration for 7d. Eye changes were observed before and after daily dosing, and 1, 24, 48, 72h and 7d after the last dosing, eye drops were rinsed with 1% sodium fluorescein and the rabbit eyes were examined with a slit lamp for conjunctiva, cornea, iris and other observed lesions and scored according to the eye irritation scoring criteria of table 3.
TABLE 3 eye irritation scoring criteria
TABLE 3 eye irritation scoring criteria
Killing experimental animals and taking materials
At the end of the 3 month observation period following dosing, animals were sacrificed using air embolism. Meanwhile, the eyeballs are taken for pathological preparation.
Evaluation of results
According to SOP/LOC-008-1-1 standard operation procedure for eye irritation test, according to the requirements of Table 3, the irritation response scores of cornea, iris and conjunctiva of each animal at each observation time are added to obtain total integral, and the integral sum of one group is divided by the animal number to obtain final score. The degree of irritation was judged according to the eye irritation evaluation criteria, as shown in Table 4. Meanwhile, pathological changes of tissues such as anterior segments (including cornea, iris and conjunctiva) and posterior segments (crystalline lens, retina and choroid) of eyes are observed and evaluated by reading pathological sections of eyeballs.
TABLE 4 evaluation criteria for eye irritation
TABLE 5 eye irritation response score table
When eye irritation was observed, no irritation was observed in the conjunctiva, cornea, and iris of eyes of both groups of 6 rabbits, and no other damage was observed. Pathological changes are not seen in the pathological section of eyeball, and tissues such as anterior segment (including cornea, iris and conjunctiva) and posterior segment (lens, retina and choroid) of eye are observed.
The test results showed that neither the test group nor the control group had ocular irritation.
7. Example seven human trial experiments selected volunteers, male and female were not limited, aged 6-18 years, were healthy, had no eye disease, and were 30 total people. The method adopts a blind test and a left-right eye comparison method, namely, one eye is applied to the eye protection patch (test) prepared in the second embodiment of the invention, and the other eye is applied to the normal saline eye protection patch (comparison), and the left eye and the right eye are alternately tested in a random double-blind way each time, namely, a subject does not know whether the eye is applied to a test product or a comparison product; the adhesive is continuously applied for 7d twice a day for 15-20 minutes each time. Before and after each application, eyes of a tester are checked, subjective feeling and using effect are inquired, and records are made in time.
Test results the test drug showed 1 case of slight discomfort, mainly slight fever and itching; the control drug was 0.
Other people have no uncomfortable feeling, most people show that the cool comfort level and the moisturizing and anti-dry eye effect of the test medicine are better than those of the reference medicine, and the test medicine has a clear and bright feeling after the test medicine is moistened.
8. Example eight
In the using process of the external composition for preventing and delaying myopia, the human body trial effect test is carried out through the second eye patch of the embodiment and the third massage cream of the embodiment.
90 volunteers meeting the conditions are selected, myopic patients aged 7-12 years old are unlimited for men and women, binocular myopia is selected in < -0.5D < -3D and no other eye disease patients are selected, and the volunteers are randomly divided into 3 groups of 30 people. Under the coordination and supervision of parents, the eye protection plaster prepared by the embodiment II of the invention is applied to eyes in the test 1 group, the eyes are tightly closed in the test 2 group, the massage cream prepared by the embodiment III of the invention is used for massaging acupoints such as Zanzhu, yangbai, yuyao, sun, sibai, qiuzhu, jingming and the like for about 30 minutes around eyes, and the eye protection plaster prepared by the embodiment III of the invention is applied to eyes in the test 3 group which is a comparison group. 2 times per day for 6 months. The vision inspection is carried out before each group of medicines is used, and the vision inspection is carried out after the medicines are used for 3 and 6 months respectively.
Curative effect judgment standard:
the effect is shown: vision improvement-1D and above;
the method is effective: slightly improving vision or maintaining the vision without reduction;
invalidation: vision continues to decline.
The test results are shown in the following table:
the trial result shows that the eye plaster and the eye massage cream of the composition have obvious effects of preventing and delaying myopia.
The external eye medicament prepared by the invention has no adverse reaction and toxic or side effect in human body trial, and the safety of the medicament is proved.
Claims (10)
1. A topical composition for preventing and treating myopia and its preparation method, characterized by, by resolving hard mass detumescence, pathogenic fire purging and qi lowering traditional Chinese medicine Prunellae Spica, thallus laminariae, radix Trichosanthis, rhizoma Dioscoreae Bulbiferae, bulbus Fritillariae Cirrhosae, inulae flos, mirabilitum, fructus Aurantii and blood breaking and stasis expelling, qi promoting and pain relieving traditional Chinese medicine rhizoma Sparganii, curcumae rhizoma, semen Persicae, hirudo, puerarin, folium Ginkgo, radix Angelicae sinensis, carthami flos, rhizoma Ligustici Chuanxiong, notoginseng radix, fructus Leonuri, caulis Spatholobi, olibanum, myrrha, saviae Miltiorrhizae radix, wind dispelling and heat clearing away, eyesight improving and nebula removing traditional Chinese medicine flos Eriocauli, flos Chrysanthemi, fructus Broussonetiae, fructus Tribuli, semen Cassiae, margarita, concha Margaritifera (layer powder), concha Haliotidis, folium Mori, radix Gentianae, herba Menthae, herba Schizonepetae, and other deficiency tonifying traditional Chinese medicine such as radix Ginseng, radix Codonopsis, radix astragali, atractylodis rhizoma, radix asparagi, radix Ophiopogonis, fructus Ligustri Lucidi, radix Adenophorae, radix Glehniae, radix Morindae officinalis, rhizoma Polygonati, fructus Schisandrae chinensis, poria, rhizoma Acori Graminei, and the like, and it is prepared into topical patch for preventing and treating myopia, eye diseases, and its preparation, such as eye drop, and eye drop, and eye drop.
2. The external composition for preventing and treating myopia and the preparation method thereof according to claim 1, wherein the external composition is characterized by comprising the traditional Chinese medicines of selfheal, kelp, radix trichosanthis, inula flower, mirabilitum, fructus aurantii, blood breaking, stasis removing, qi circulation promoting and pain relieving traditional Chinese medicines of rhizoma sparganii, rhizoma curcumae, leech, puerarin, ginkgo leaf, angelica sinensis, safflower, pseudo-ginseng, motherwort fruit and root of red-rooted salvia, the traditional Chinese medicines of pipewort, chamomile, fructus Broussonetiae, caltrop, mother-of-pearl (layer powder), concha haliotidis, gentian and herba schizonepetae, the traditional Chinese medicines of tonifying qi, nourishing blood, soothing the nerves, promoting intelligence, nourishing yin, tonifying yang and the like, the traditional Chinese medicines of ginseng, astragalus, radix rehmanniae, radix asparagi, glossy privet fruit, epimedium, fructus psoraleae, medlar, shizandra, rhizoma acori graminei, and the like.
3. The composition for external use for preventing and treating myopia and its preparation method according to claim 1 and 2, wherein: the traditional Chinese medicine is prepared from common selfheal fruit-spike, kelp, inula flower, mirabilite, common burreed rhizome, puerarin, chinese angelica, safflower, motherwort fruit, chinese angelica root, common burreed rhizome, auxiliary materials of wind dispelling, heat clearing, eyesight improving and nebula removing, chinese medicinal pipewort, fructus Broussonetiae, caltrop, mother-of-pearl (layer powder) and gentian, auxiliary materials of qi supplementing, blood nourishing, nerve soothing, intelligence improving, yin nourishing, yang strengthening and other deficiency tonifying traditional Chinese medicines of ginseng, astragalus mongholicus, radix rehmanniae, radix asparagi, epimedium, schisandra chinensis, poria cocos, rhizoma acori graminei and the like.
4. A topical composition for preventing and treating myopia and its preparation method according to claims 1, 2 and 3, wherein the best choice formulation comprises by weight: 3-12 parts of selfheal, 3-12 parts of kelp, 4-18 parts of inula flower, 1-9 parts of mirabilite, 2-10 parts of rhizoma sparganii, 0.2-2 parts of puerarin, 5-15 parts of angelica, 2-10 parts of safflower, 3-12 parts of motherwort fruit, 3-18 parts of pipewort, 2-10 parts of fructus Broussonetiae, 1-8 parts of fructus tribuli, 10-50 parts of pearl powder, 0.5-5 parts of gentian, 2-10 parts of ginseng, 3-12 parts of astragalus mongholicus, 3-15 parts of radix rehmanniae, 3-15 parts of radix asparagi, 5-20 parts of epimedium, 1-6 parts of schisandra chinensis, 3-12 parts of poria cocos and 1-6 parts of rhizoma acori graminei. The above Chinese medicinal materials are used for extracting effective components according to their characteristics and medicinal requirements, and adding pharmaceutically acceptable adjuvants into the extracts to make into topical preparations for eye such as patch, unguent, cream, emulsion, patch, etc.
5. The composition for external use for preventing and treating myopia and its preparation method according to claims 1, 2, 3 and 4, wherein the best choice formulation is optimized by weight: 5-10 parts of selfheal, 5-10 parts of kelp, 6-15 parts of inula flower, 2-8 parts of mirabilite, 3-9 parts of rhizoma sparganii, 0.3-1.5 parts of puerarin, 6-12 parts of angelica, 3-8 parts of safflower, 5-10 parts of motherwort fruit, 20-40 parts of pearl powder, 6-15 parts of pipewort, 3-8 parts of fructus Broussonetiae, 2-7 parts of fructus tribuli, 0.8-4 parts of gentian, 2-8 parts of ginseng, 4-10 parts of radix astragali, 5-12 parts of radix rehmanniae, 5-12 parts of radix asparagi, 6-16 parts of epimedium, 2-6 parts of schisandra chinensis, 5-10 parts of white poria and 2-6 parts of rhizoma acori graminei. The above Chinese medicinal materials are used for extracting effective components according to their characteristics and administration requirements, and adding various extracts into pharmaceutically acceptable adjuvants to make into topical preparations for eye such as patch, unguent, cream, emulsion, patch, etc.
6. A topical composition for preventing and treating myopia and its preparation according to claims 1, 2, 3, 4, 5, wherein the best further choice formulation is further optimized in parts by weight: 6-9 parts of selfheal, 6-9 parts of kelp, 8-14 parts of inula flower, 3-8 parts of mirabilite, 4-9 parts of rhizoma sparganii, 0.5-1.2 parts of puerarin, 8-10 parts of angelica, 4-6 parts of safflower, 6-9 parts of motherwort fruit, 22-36 parts of pearl powder, 8-12 parts of pipewort, 4-6 parts of fructus Broussonetiae, 2-6 parts of fructus tribuli, 1-3 parts of gentian, 2-6 parts of ginseng, 4-8 parts of astragalus mongholicus, 6-12 parts of radix rehmanniae, 8-12 parts of radix asparagi, 8-15 parts of epimedium, 2-5 parts of schisandra chinensis, 5-9 parts of poria cocos and 2-5 parts of rhizoma acori graminei. The above Chinese medicinal materials are extracted according to their respective characteristics and requirements, and various extracts are added into pharmaceutically acceptable adjuvants to make into topical preparations for eye such as patch, unguent, cream, emulsion, patch, etc.
7. The external composition for preventing and treating myopia and its preparation method according to claim 1, 2, 3, 4, 5 and 6, further comprising transdermal absorption enhancer, humectant and pharmaceutically acceptable adjuvants.
8. The composition for external use for preventing and treating myopia and its preparation method according to claim 7, wherein the percutaneous absorption enhancer comprises one or more of Borneolum Syntheticum, natural borneol (D-borneol), menthol, camphor, eucalyptus oil, oleic acid, azone, dimethyl sulfoxide, etc. The humectant includes, but is not limited to, one or more of trehalose, oat beta-glucan, polyethylene glycol, glycerol, propylene glycol, butylene glycol, hexylene glycol, xylitol, sorbitol, PVP-K30, sodium hyaluronate, panthenol, ceramides, sodium Pyrrolidone Carboxylate (PCA).
9. The external composition for preventing and treating myopia and its preparation method according to claim 1, 2, 3, 4, 5, 6, 7, 8, wherein the preparation method is as follows:
(1) Pulverizing Inulae flos, rhizoma Sparganii, radix Angelicae sinensis, fructus Leonuri, flos Eriocauli, fructus Tribuli, and rhizoma Acori Graminei into coarse powder, distilling with steam, extracting volatile oil, and storing in a container;
(2) Adding Prunellae Spica, thallus laminariae, carthami flos, fructus Broussonetiae, ginseng radix, radix astragali, radix rehmanniae, radix asparagi, and Poria into the medicinal liquid and residue after extracting volatile oil; decocting herba Epimedii, fructus Schisandrae chinensis, and radix Gentianae with water twice, adding 10 times of water for the first time, boiling for 3 hr, adding 8 times of water for the second time, boiling for 2 hr, filtering, concentrating the extractive solution, adding ethanol to precipitate for two times until ethanol content is 50-80%, and recovering ethanol to obtain Chinese medicinal extract;
(3) Adding 3-8 amount of water into the nacreous layer powder, boiling, maintaining the temperature for 6-60 hours, filtering, and concentrating to obtain nacreous layer powder extract;
(4) Adding nacreous layer powder extract into the Chinese medicinal extract, stirring, adding borax, mirabilitum, PVP-K30 and puerarin, stirring for dissolving;
(5) And (3) adding the solubilizing agent Tween-80 into the extracted volatile oil, uniformly mixing, adding the volatile oil into the liquid medicine prepared in the step (4), uniformly mixing, and adding glycerol, propylene glycol, phenoxyethanol and ethylparaben, and stirring to dissolve. And finally, slowly adding the natural borneol and menthol ethanol solution under stirring, regulating the pH value to be between 6.4 and 7.8 by using disodium hydrogen phosphate solution or sodium dihydrogen phosphate solution, adding water to the whole amount, uniformly mixing, filtering, filling into an eye-protecting adhesive carrier such as pure cotton cloth, natural silk cloth aluminum-plastic composite film bag or other containers which are cut into a certain shape, and sealing.
10. The external composition for preventing and treating myopia and its preparation method according to claim 1, 2, 3, 4, 5, 6, 7, 8, wherein the preparation method is as follows:
A. pulverizing Inulae flos, rhizoma Sparganii, radix Angelicae sinensis, fructus Leonuri, flos Eriocauli, fructus Tribuli, herba Epimedii, fructus Schisandrae chinensis, radix Gentianae, and rhizoma Acori Graminei into coarse powder, adding 60-85% ethanol solution of 6-8 times of the powder, ultrasonic extracting the ethanol soaked material for 1.5 hr, filtering, adding 3-4 times 60-85% ethanol solution into the residue, ultrasonic extracting for 1.0 hr, and filtering. Combining the two filtrates, and recovering ethanol. Obtaining ethanol extract;
B. decocting Prunellae Spica, thallus laminariae, carthami flos, fructus Broussonetiae, ginseng radix, radix astragali, radix rehmanniae, radix asparagi, and Poria with water twice, adding 10 times of water in the first time, boiling for 3 hr, adding 8 times of water in the second time, boiling for 2 hr, filtering, mixing extractive solutions, and concentrating to obtain Chinese medicinal extract;
C. adding 3-8 amount of water into the nacreous layer powder, boiling, maintaining the temperature for 6-60 hours, filtering, and concentrating to obtain nacreous layer powder extract;
D. adding nacreous layer powder extract and ethanol extract into the Chinese medicinal extract, stirring, mixing, adding borax, mirabilitum, and Tween-80 as solubilizer, PVP-K30 and puerarin, natural Borneolum Syntheticum, mentholum, glycerol, propylene glycol, phenoxyethanol, and ethylparaben, stirring, mixing, adding adjuvant, and adjusting pH to 6.4-7.8 with disodium hydrogen phosphate solution or sodium dihydrogen phosphate solution to obtain eye massage cream; or adding emulsion matrix, etc., and making into cream, lotion, patch, etc.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310435664.XA CN116672421A (en) | 2023-04-21 | 2023-04-21 | A topical composition for preventing and treating myopia, and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310435664.XA CN116672421A (en) | 2023-04-21 | 2023-04-21 | A topical composition for preventing and treating myopia, and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116672421A true CN116672421A (en) | 2023-09-01 |
Family
ID=87782546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310435664.XA Pending CN116672421A (en) | 2023-04-21 | 2023-04-21 | A topical composition for preventing and treating myopia, and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116672421A (en) |
-
2023
- 2023-04-21 CN CN202310435664.XA patent/CN116672421A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101773653B (en) | Chinese medicine composition for treating ablepsia and preparation method thereof | |
CN104069364A (en) | Traditional Chinese medicine for treating optic atrophy | |
CN109200196B (en) | Dendrobium nobile alkaloid eye mask and preparation method thereof | |
CN107260808A (en) | A kind of liniment for alleviating visual fatigue and its production and use | |
CN104971304A (en) | Xerophthalmia treatment medicine | |
CN104547622A (en) | Traditional Chinese medicine preparation for treating cataract and preparation method of traditional Chinese medicine preparation | |
CN109954125A (en) | It is a kind of to treat near-sighted Chinese medicine lotion for external use and preparation method thereof | |
CN102784301B (en) | Traditional Chinese medicine treating early cataract and its preparation method | |
CN112121104B (en) | Traditional Chinese medicine composition for relieving asthenopia and preventing and treating myopia | |
CN116672421A (en) | A topical composition for preventing and treating myopia, and its preparation method | |
CN108210714A (en) | It is a kind of for pharmaceutical composition of eye surface diseases and preparation method thereof and purposes | |
CN106344827A (en) | Eye drops for treating presbyopia and preparation method of eye drops | |
CN104606367A (en) | Traditional Chinese medicine eye drop for treating liver and kidney insufficiency myopia, and preparation method thereof | |
CN104524479A (en) | Traditional Chinese medicine composition for treating premenstrual syndrome and preparation method of traditional Chinese medicine composition | |
CN110478442A (en) | A kind of Multifunctional eye drops and preparation method thereof | |
CN112274558B (en) | Pharmaceutical composition for treating under-eye puffiness and dark circles and preparation method and application thereof | |
CN109731088A (en) | A kind of Traditional Chinese medicine composition for relieving asthenopia and its preparation method and application | |
CN103860736A (en) | Chinese herba preparation for treating cataract and preparation method thereof | |
CN103520610B (en) | Traditional Chinese medicine composition for relieving asthenopia and preparation method thereof | |
CN113893087B (en) | Chinese medicine eye-mask for regulating myopia, amblyopia, astigmatism and asthenopia and its making method | |
CN108498615A (en) | A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle | |
CN117883524B (en) | Liver nourishing and eyesight improving composition and preparation method and application thereof | |
CN107714768A (en) | A kind of Chinese medicine composition for treating interior external opculopathy disease and its preparation method and application | |
CN110101799B (en) | Tea bag for treating xerophthalmia and preparation method thereof | |
CN1089605C (en) | Capsule for treatment of leukoderma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |